The clinical application of transcranial magnetic stimulation

Psychiatric Annals

Volumn 44, Issue 6, 2014, Pages 305-309

  Hutton, Todd M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84903382229     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20140609-09     Document Type: Article

References (8)

1. Shinjuku Mental Clinic I-land Tower. TMS treatment. http://www.shinjuku_mental.com/sp/en/. Accessed May 30, 2014.
2. Neurostar. NeuroStar TMS Therapy System User Manual. http://neurostar.com/wp-content/uploads/NeuroStar-PrescribingInformation.pdf. Published June 28, 2013. Accessed May 30, 2014.
3. Anthem. Transcranial magnetic stimulation: Medical policy. http://www.anthem.com/ medicalpolicies/policies/mp_pw_a047769.htm. Effective April 15, 2014. Accessed May 30, 2014.
4. Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clini-cal response in an open-label extension trial. J Clin Psychiatry. 2008;69(3):441-451.
5. Harel EV, Rabany L, Deutsch L, Bloch Y, Zangen A, Levkovitz Y. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study. World J Biol Psychiatry. 2014;15(4):298-306.
6. Nova. The Uses of TMS: Expert Q&A. http://www.pbs.org/wgbh/nova/body/george-uses-tms.html. Posted January 20, 2011. Accessed May 30, 2014.
7. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical beneft with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul. 2010;3(4):187-199.
8. Demitrack M, Dunner D, Carpenter L, et al. A multisite, longitudinal, naturalistic observational study of transcranial magnetic stimulation for major depression in clinical practice. Poster presented at: 166th Annual Meeting of the American Psychiatric Association; May 18-22, 2013; San Francisco, CA.